课题基金 / 基金详情

Novel therapeutic modality for metastatic bone disease of breast cancer via hyaluronan inhibition

Novel therapeutic modality for metastatic bone disease of breast cancer via hyaluronan inhibition
通过乙酰透明质酸抑制治疗乳腺癌转移性骨病的新方法
批准号:
20591751
负责人:
NISHIDA Yoshihiro
金额:
$2.83万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

NISHIDA Yoshihiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
4-MU (4-methylumbelliferone), an inhibitor for hyaluronan synthesis, and hyaluronan oligosaccharides, which has shown to suppress endogenous hyaluronan, effectively showed anti-tumor effect on breast and lung cancer. Moreover, these reagents significantly suppressed metastatic bone lesion of breast and lung cancer without serious complications. Together, 4-MU and hyaluronan oligosaccharides might be a promising novel therapeutic tools for metastatic bone disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibition of hyaluronan synthesis suppresses tumorigenicity of osteosarcoma cells, LM-8, in vitro and in vivo via depletion of hyaluronan-rich pericellular matrix of the cells.
抑制透明质酸合成可通过消耗富含透明质酸的细胞周基质来抑制骨肉瘤细胞 LM-8 在体外和体内的致瘤性。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Nishida Y, Kamada T, Imai R, Tsukushi S, Yamada Y, Sugiura H, Shido Y, Wasa J, Ishiguro N., Urakawa H, Futamura N, Urakawa H, Futamura N, 浦川浩, Nishida Y, Nishida Y, Urakawa H, Urakawa H, Arai E]
通讯作者: Arai E
Inhibition of hyaluronan synthesis in breast cancer cells by 4-Methylumbelife rone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo.
4-Mmethylumbelife rone 抑制乳腺癌细胞中透明质酸的合成,可抑制体外致瘤性和体内骨转移性病变。
DOI: --
发表时间: 2011
期刊: Int J Cancer
影响因子: 6.4
作者: [Nishida Y, Kamada T, Imai R, Tsukushi S, Yamada Y, Sugiura H, Shido Y, Wasa J, Ishiguro N., Urakawa H]
通讯作者: Urakawa H
Hyaluronan plays significant roles not only in maintenance of musculoskeletal systems but also in tumorigenicity of musculoskeletal malignant tumors.
透明质酸不仅在维持肌肉骨骼系统方面发挥着重要作用,而且在肌肉骨骼恶性肿瘤的致瘤性中也发挥着重要作用。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Nishida Y, Kamada T, Imai R, Tsukushi S, Yamada Y, Sugiura H, Shido Y, Wasa J, Ishiguro N., Urakawa H, Futamura N, Urakawa H, Futamura N, 浦川浩, Nishida Y]
通讯作者: Nishida Y
DOI: 10.1016/j.ijrobp.2009.10.051
发表时间: 2011-01-01
期刊: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
影响因子: 7
作者: [Nishida, Yoshihiro, Kamada, Tadashi, Ishiguro, Naoki]
通讯作者: Ishiguro, Naoki
11
    Design, syntheses and diagnostic applications of beta(1-6)-linked glycolipids (GGLs) as the major cell membrane components of Mycoplasma pneumoniae
    • 批准号:
      25450146
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2013
    • 负责人:
      NISHIDA Yoshihiro
    • 依托单位:
    New evaluation of fetal oxidative stress: measurement of the umbilical cord blood dimethyl sulfate-induced ascorbyl free radical by an electron spin resonance method
    • 批准号:
      24659734
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      NISHIDA Yoshihiro
    • 依托单位:
    Development of a novel conservative therapeutic modality for patients with bone metastasis focusing on hyaluronan network
    • 批准号:
      23592181
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      NISHIDA Yoshihiro
    • 依托单位:
    Module Assembly and Evaluation of Artificial Glycosaminoglycans
    国内基金
    海外基金
    HP靶向及TCb化疗联合乳癌术后方在HER2阳性乳腺癌患者中的前瞻性研究
    • 批准号:
      2024QN036
    • 项目类别:
      省市级项目
    • 资助金额:
      4.0万元
    • 批准年份:
      2024
    • 负责人:
      吴鸣远
    • 依托单位:
    circEMCN编码多肽EMCN-81激活STAT3/VEGF通路调控炎性乳癌血管生成促进恶性进展的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      林颖
    • 依托单位:
    CTSK调控ACSs-乳腺癌细胞交互功能促进脂肪移植乳癌术后重建的机制研究